Literature DB >> 7704214

Simultaneous determination of dihydrocodeine and dihydromorphine in serum by gas chromatography-tandem mass spectrometry.

U Hofmann1, M F Fromm, S Johnson, G Mikus.   

Abstract

A sensitive and specific method was developed for the determination of dihydrocodeine and its metabolite dihydromorphine in human serum using codeine and morphine as internal standards. Measurement is performed with GC-tandem MS after one simple extraction step and derivatization to the pentafluoropropionic esters. Sensitivity of the method is excellent and allows for the reproducible quantification of dihydrocodeine and dihydromorphine with limits of quantification of 2 ng/ml and 40 pg/ml serum, respectively. The method is therefore well suited for investigation of the pharmacokinetics and the metabolism of dihydrocodeine.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7704214     DOI: 10.1016/0378-4347(94)00423-3

Source DB:  PubMed          Journal:  J Chromatogr B Biomed Appl        ISSN: 1572-6495


  4 in total

1.  Contribution of dihydrocodeine and dihydromorphine to analgesia following dihydrocodeine administration in man: a PK-PD modelling analysis.

Authors:  J A Webb; A Rostami-Hodjegan; R Abdul-Manap; U Hofmann; G Mikus; F Kamali
Journal:  Br J Clin Pharmacol       Date:  2001-07       Impact factor: 4.335

2.  Impact of quinidine on plasma and cerebrospinal fluid concentrations of codeine and morphine after codeine intake.

Authors:  S H Sindrup; U Hofmann; J Asmussen; G Mikus; K Brøsen; F Nielsen; S H Ingwersen; C Broen Christensen
Journal:  Eur J Clin Pharmacol       Date:  1996       Impact factor: 2.953

3.  Pharmacokinetics of dihydrocodeine and its active metabolite after single and multiple oral dosing.

Authors:  S Ammon; U Hofmann; E U Griese; N Gugeler; G Mikus
Journal:  Br J Clin Pharmacol       Date:  1999-09       Impact factor: 4.335

4.  The visceral and somatic antinociceptive effects of dihydrocodeine and its metabolite, dihydromorphine. A cross-over study with extensive and quinidine-induced poor metabolizers.

Authors:  C H Wilder-Smith; E Hufschmid; W Thormann
Journal:  Br J Clin Pharmacol       Date:  1998-06       Impact factor: 4.335

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.